LBA35 Avelumab-cetuximab-radiotherapy versus standards of care in patients with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Randomized phase III GORTEC-REACH trial

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

European Journal of Cancer ◽

10.1016/j.ejca.2020.09.008 ◽

2020 ◽

Vol 141 ◽

pp. 21-29

Author(s):

Yungan Tao ◽

Anne Aupérin ◽

Xushan Sun ◽

Christian Sire ◽

Laurent Martin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Standards Of Care ◽

Phase Iii Trial

910O Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1025 ◽

2020 ◽

Vol 31 ◽

pp. S658 ◽

Cited By ~ 1

Author(s):

E.E. Cohen ◽

R.L. Ferris ◽

A. Psyrri ◽

R. Haddad ◽

M. Tahara ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Head Neck

Results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.6000 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 6000-6000 ◽

Cited By ~ 3

Author(s):

Vijay Maruti Patil ◽

Vanita Noronha ◽

Amit Joshi ◽

Jaiprakash Agarwal ◽

Sarbani Ghosh Laskar ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Concurrent Radiotherapy ◽

Phase Iii Study

Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.6004 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 6004-6004 ◽

Cited By ~ 29

Author(s):

Maria Grazia Ghi ◽

Adriano Paccagnella ◽

Daris Ferrari ◽

Paolo Foa ◽

Maria Cossu Rocca ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Concomitant Chemoradiation

Avelumab-cetuximab-radiotherapy versus standards of care (SoC) in patients (pts) with locally advanced squamous cell carcinoma of head and neck (LA-SCCHN): Safety phase of randomized trial GORTEC 2017-01 (REACH)

Annals of Oncology ◽

10.1093/annonc/mdz252.010 ◽

2019 ◽

Vol 30 ◽

pp. v454

Author(s):

Y. Tao ◽

A. Auperin ◽

X. Sun ◽

C. Sire ◽

L. Martin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Standards Of Care ◽

Avelumab-cetuximab-radiotherapy (RT) versus standards of care (SoC) in locally advanced squamous cell carcinoma of the head and neck (SCCHN): Safety phase of the randomized trial GORTEC 2017-01 (REACH).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.6076 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 6076-6076 ◽

Cited By ~ 12

Author(s):

Yungan Tao ◽

Anne Auperin ◽

Xu Shan Sun ◽

Christian Sire ◽

Laurent Martin ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Standards Of Care ◽

Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial

Cancer/Radiothérapie ◽

10.1016/s1278-3218(02)00188-9 ◽

2002 ◽

Vol 6 (5) ◽

pp. 326-328

Author(s):

G Noël ◽

J.J Mazeron

Keyword(s):

Squamous Cell Carcinoma ◽

Randomized Trial ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Accelerated Radiotherapy

Phase III trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck

http://isrctn.org/> ◽

10.1186/isrctn52466525 ◽

2012 ◽

Author(s):

Jose Luis Aguilar Ponce

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Phase Iii ◽

Phase Iii Trial

Faculty Opinions recommendation of Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3359960.3049058 ◽

2010 ◽

Author(s):

David Potter

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Locally Advanced ◽

Prospective Trial ◽

Paclitaxel and Carboplatin Concurrent with Three-Dimensional Conformal Radiotherapy (3D-CRT ) for Treatment of Locally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)

Research in Oncology ◽

10.21608/resoncol.2013.453 ◽

2013 ◽

Vol 9 (Issue 1-2) ◽

pp. 27-32

Author(s):

S. Abdelwahab ◽

R. Ghali ◽

M. Elbassiouny ◽

A. Elsayed ◽

A. Mahmoud ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Three Dimensional ◽

Conformal Radiotherapy ◽

Three Dimensional Conformal Radiotherapy ◽

3D Crt